Crinetics Pharmaceuticals, Inc.CRNXNASDAQ
Loading
Revenue ScalingExpanding
Percentile Rank100
3Y CAGR+17.6%
5Y CAGR+155.3%
Studio
Year-over-Year Change

Total revenue from sales of goods and services

3Y CAGR
+17.6%/yr
vs +18.2%/yr prior
5Y CAGR
+155.3%/yr
Recent deceleration
Acceleration
-0.6pp
Decelerating
Percentile
P100
Near historical high
vs 5Y Ago
108.4x
Strong expansion
Streak
1 yr
Consecutive growthExpanding
PeriodValueYoY Change
2025$7.70M+640.7%
2024$1.04M-74.1%
2023$4.01M-15.3%
2022$4.74M+339.4%
2021$1.08M+1418.3%
2020$71000.00-94.0%
2019$1.19M-50.9%
2018$2.43M+18.7%
2017$2.04M+247.2%
2016$589000.00-